Press releases
Prime Therapeutics welcomes new client success leader
DeZearn to lead our client teams and help ensure Prime’s client relationships are collaborative, accountable, responsive and aligned
April 26, 2021As vice president of client success, DeZearn is responsible for leading our client teams and helping to ensure Prime’s client relationships are collaborative, accountable, responsive and aligned. DeZearn is a licensed clinical pharmacist and has extensive pharmacy benefit management industry experience with sales and account management.
In her nearly 30-year career, DeZearn has led clinical and sales/account management teams at Diversified Pharmaceutical Services, Merck-Medco Managed Care, Medco Health Solutions, Anthem and most recently, Express Scripts. She has led initiatives in benefit design, clinical and formulary management aimed at lowering overall drug costs.
“Karen is a team-oriented, metric driven leader who possesses the skills needed for Prime to continue to evolve its client relationships to be more strategic and mutually beneficial,” said Dave Schlett, chief financial officer.
DeZearn holds a Doctor of Pharmacy degree from Campbell University School of Pharmacy in North Carolina.
Related news
Press releases
September 6, 2024
Prime Therapeutics recognized at PBMI for award-winning solutions, leaders
At Pharmacy Benefit Management Institute (PBMI) annual conference, Prime received two awards: one for cost savings, another for leadership.
Press releases
July 10, 2024
Prime continues to lead industry on GLP-1 research: 1 in 7 stays on GLP-1 drugs for weight loss after two years
Real-world, integrated data follows-up on previous insights, analytics.
Press releases
July 8, 2024
Prime Therapeutics hires new CIO to lead digital transformation
Dinesh Kandanchatha joined the organization July 1.